
Stigmerase 2.5mg Injection
Marketer
Miracalus Pharma Pvt Ltd
Salt Composition
Neostigmine (2.5mg)
Overview Stigmerase 2.5mg Injection
Myasthenia gravis, paralytic ileus, postoperative urinary retention, and the effects of neuromuscular blocking agents post-surgery are all treatable with the prescription medication Stigmerase 2.5mg Injection. This injectable formulation alleviates muscle weakness. Administered by a healthcare provider, it requires adherence to the prescribed dosage and completion of the full treatment course; abrupt cessation should only occur under medical guidance. Prior to use, disclose any pre-existing kidney disease, Parkinson's disease, asthma, or gastrointestinal issues to your physician. Bradycardia, nausea, and emesis are commonly reported adverse reactions. Report any suspected drug-related symptoms to your doctor, who can advise on mitigating strategies. Pregnant or lactating individuals should seek medical consultation before initiating treatment.
Uses of Stigmerase 2.5mg Injection
Managing myasthenia gravis, addressing paralytic ileus, resolving postoperative urinary retention, and counteracting the effects of neuromuscular blockade post-surgery.
Major Benefits of Stigmerase 2.5mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
Common Side effects of Stigmerase 2.5mg Injection:
- Nausea
- Vomiting
- Slow heart rate
How to use Stigmerase 2.5mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Stigmerase 2.5mg Injection works:
Stigmerase 2.5mg Injection acts by reversibly inhibiting cholinesterase. This elevates acetylcholine, a neurotransmitter, within the brain through acetylcholinesterase suppression. The resulting increase in acetylcholine subsequently stimulates muscle receptors, facilitating muscle contraction.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Stigmerase 2.5mg Injection and alcohol may result in increased somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering Stigmerase 2.5mg Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to its prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Administration of Stigmerase 2.5mg Injection while breastfeeding appears to pose minimal risk. Available human data indicate negligible danger to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Stigmerase 2.5mg Injection on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneyCAUTION
Exercise caution when administering Stigmerase 2.5mg Injection to individuals with impaired renal function. Dosage modification of Stigmerase 2.5mg Injection might be necessary. Physician consultation is recommended. Routine assessment of kidney function and certain blood parameters may be advisable during treatment.
LiverSAFE IF PRESCRIBED
Stigmerase 2.5mg Injection appears to pose minimal risk for individuals with hepatic impairment. Available evidence indicates that dosage modification of Stigmerase 2.5mg Injection is likely unnecessary in this population. Physician consultation is recommended.
What if you forget to take Stigmerase 2.5mg Injection :
Should you forget a dose of Stigmerase 2.5mg Injection, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Stigmerase 2.5mg Injection
| Label | Value |
|---|---|
| Chemical Category | Organophosphates |
| Developing Good Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Active Class | Carbamate cholinesterase inhibitors |
